ARTICLE | Company News
PerkinElmer ADMET deal with Kibron
July 11, 2001 7:00 AM UTC
PKI received exclusive worldwide rights, outside Japan, to Kibron's ADMET products, for use in drug discovery research. PKI took a 10% equity stake in Kibron (Helsinki, Finland), and has an option to ...